Physician

Bernard Joseph Durante, MD

According to 2025 Medicare claims, Bernard Durante, MD (NPI: 1164400040) practices otolaryngology in the Boston, MA market, with the plurality of this provider's patient population coming from Plymouth, MA. This provider's primary affiliated billing organization is BERNARD J DURANTE MD PC (NPI: 1114024312; TIN: 043585201) and primary practice location at 02360-4804. Durante is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490) and Aledade 205 New England MSSP Enhanced (ACO ID: A5370), participating under the MSSP model.

Durante's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,524 traditional Medicare patients, billed 21,803 HCPCS/CPT codes, and received $1,139,797 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 4,202 prescription claims across 1,213 beneficiaries totaling $352,884 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 7,281 claims. Open Payments data shows 5 records totaling $97. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $521,908 to $1,139,797. Similarly, Part D prescription costs have moved sharply higher in recent years, from $41,938 to $352,884. For DME billing, reported payments moved sharply higher in recent years, from $91,344 to $330,568.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,234	9,509	$521,908
2016	1,171	8,072	$540,105
2017	1,375	11,601	$611,161
2018	1,463	19,119	$644,784
2019	1,758	21,551	$770,075
2020	1,456	17,184	$594,722
2021	1,871	25,204	$849,681
2022	2,182	25,081	$988,538
2023	2,402	27,610	$1,120,893
2024	2,524	21,803	$1,139,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	397	1,313	$41,938
2016	398	1,354	$36,390
2017	448	1,649	$53,766
2018	506	1,882	$57,055
2019	594	1,926	$57,745
2020	585	2,025	$80,233
2021	709	2,555	$102,105
2022	829	2,950	$249,322
2023	977	3,313	$344,085
2024	1,213	4,202	$352,884

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,046	2,142	$91,024
2016	1,440	3,130	$114,215
2017	1,727	3,958	$124,669
2018	1,845	3,814	$123,573
2019	2,374	4,893	$168,470
2020	2,291	5,236	$190,088
2021	2,219	4,383	$174,170
2022	2,325	5,016	$224,073
2023	2,820	6,213	$292,858
2024	3,182	7,281	$319,559

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	1,512	2,121	$148
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	757	757	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,041	1,552	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,182	1,765	$65
76536	Ultrasound scan of head and neck soft tissue	200	381	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	32	1,008	$133,766
Xolair	Omalizumab	21	588	$77,582
Azelastine Hcl	Azelastine Hcl	703	42,378	$26,798
Fluticasone Propionate	Fluticasone Propionate	852	53,160	$13,848
Ipratropium Bromide	Ipratropium Bromide	399	13,376	$10,158

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	188	405	$42,232
E0601	Continuous positive airway pressure (cpap) device	Y	253	1,332	$40,397
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	439	997	$37,691
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	305	733	$37,200
A7030	Full face mask used with positive airway pressure device, each	N	190	434	$36,915

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$97	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bernard Joseph Durante, MD?

Tedicare shows public-source Medicare data for Bernard Joseph Durante, MD (NPI 1164400040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bernard Joseph Durante, MD have ACO affiliation data?

Bernard Joseph Durante, MD is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490) and Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370).

What billing organization is linked to Bernard Joseph Durante, MD?

Bernard Joseph Durante, MD is linked to BERNARD J DURANTE MD PC (billing NPI 1114024312) in the available physician profile data.

Does Bernard Joseph Durante, MD have Open Payments data?

Bernard Joseph Durante, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.